Emerging therapy for diabetic neuropathy: Cell therapy targeting vessels and nerves

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 12, Issue 2, 2012, Pages 168-178

  Kim, Hyongbum ^a   Kim, Julie J ^b   Yoon, Young sup ^b  

^a Hanyang University   (South Korea)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenic factors; Cell therapy; Diabetes mellitus; Diabetic neuropathy; Nerves; Neurotrophic factors; Vasa nervorum

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BRAIN DERIVED NEUROTROPHIC FACTOR; CD31 ANTIGEN; CD34 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; HEXOSAMINE; NERVE GROWTH FACTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLYOL; PROTEIN KINASE C; SOMATOMEDIN; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

ANGIOGENESIS; BONE MARROW MONONUCLEAR CELL; CAPILLARY DENSITY; CELL DIFFERENTIATION; CELL THERAPY; DIABETIC NEUROPATHY; ENDOTHELIAL PROGENITOR CELL; GENE TRANSFER; HUMAN; HYPERGLYCEMIA; MICROVASCULAR ISCHEMIA; MONONUCLEAR CELL; NERVE INJURY; NEURAL STEM CELL; NEUROTROPISM; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PLASMID; POSTNATAL DEVELOPMENT; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TRANSPORT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEM CELL EXPANSION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; ENDOTHELIAL CELLS; GENE THERAPY; HUMANS; MICE; MONOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE GROWTH FACTORS; NERVOUS SYSTEM; RATS; STEM CELL TRANSPLANTATION;

EID: 84861118805     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/187153012800493486     Document Type: Review

References (139)

1. Leinninger, G.M.; Vincent, A.M. and Feldman, E.L. (2004) The role of growth factors in diabetic peripheral neuropathy. J. Peripher. Nerv. Syst., 9(1), 26-53.
2. Jensen, M.P.; Dworkin, R.H.; Gammaitoni, A.R.; Olaleye, D.O.; Oleka, N. and Galer, B.S. (2006) Do pain qualities and spatial characteristics make independent contributions to interference with physical and emotional functioning? J. Pain, 7(9), 644-653.
3. Verrotti, A.; Loiacono, G.; Mohn, A. and Chiarelli, F. (2009) New insights in diabetic autonomic neuropathy in children and adolescents. Eur. J. Endocrinol., 161(6), 811-818.
4. Anand, P. (2004) Neurotrophic factors and their receptors in human sensory neuropathies. Prog. Brain Res., 146, 477-492.
5. Apfel, S.C. (2000) Neurotrophic factors and pain. Clin. J. Pain, 16(2), S7-11.
6. Sima, A.A. (2003) New insights into the metabolic and molecular basis for diabetic neuropathy. Cell. Mol. Life Sci., 60(11), 2445-2464.
7. Simmons, Z. and Feldman, E.L. (2002) Update on diabetic neuropathy. Curr. Opin. Neurol., 15(5), 595-603.
8. Feldman, E.L.; Russell, J.W.; Sullivan, K.A. and Golovoy, D. (1999) New insights into the pathogenesis of diabetic neuropathy. Curr. Opin. Neurol., 12(5), 553-563.
9. Verrotti, A.; Giuva, P.T.; Morgese, G. and Chiarelli, F. (2001) New trends in the etiopathogenesis of diabetic peripheral neuropathy. J. Child Neurol., 16(6), 389-394.
10. Oates, P.J. (2002) Polyol pathway and diabetic peripheral neuropathy. Int. Rev. Neurobiol., 50, 325-392.
11. Sugimoto, K.; Yasujima, M. and Yagihashi, S. (2008) Role of advanced glycation end products in diabetic neuropathy. Curr. Pharm. Des., 14(10), 953-961.
12. Obrosova, I.G.; Van Huysen, C.; Fathallah, L.; Cao, X.C.; Greene, D.A. and Stevens, M.J. (2002) An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J., 16(1), 123-125.
13. Koya, D. and King, G.L. (1998) Protein kinase C activation and the development of diabetic complications. Diabetes, 47(6), 859-66.
14. Garcia Soriano, F.; Virag, L.; Jagtap, P.; Szabo, E.; Mabley, J.G.; Liaudet, L.; Marton, A.; Hoyt, D.G.; Murthy, K.G.; Salzman, A.L.; Southan, G.J. and Szabo, C. (2001) Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat. Med., 7(1), 108-113.
15. Ilnytska, O.; Lyzogubov, V.V.; Stevens, M.J.; Drel, V.R.; Mashtalir, N.; Pacher, P.; Yorek, M.A. and Obrosova, I.G. (2006) Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes, 55(6), 1686-1694.
16. Goldberg, H.J.; Whiteside, C.I. and Fantus, I.G. (2002) The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-beta I and-delta. J. Biol. Chem., 277(37), 33833-33841.
17. Kuhad, A. and Chopra, K. (2009) Tocotrienol attenuates oxidativenitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy. Neuropharmacology, 57(4), 456-462.
18. Vincent, A.M.; McLean, L.L.; Backus, C. and Feldman, E.L. (2005) Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J., 19(6), 638-640.
19. Obrosova, I.G.; Drel, V.R.; Pacher, P.; Ilnytska, O.; Wang, Z.Q.; Stevens, M.J. and Yorek, M.A. (2005) Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes, 54(12), 3435-3441.
20. Cameron, N.E. and Cotter, M.A. (2002) Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism. Diabetes Metab. Res. Rev., 18(4), 315-323.
21. Cameron, N.E.; Gibson, T.M.; Nangle, M.R. and Cotter, M.A. (2005) Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes. Ann. N. Y. Acad. Sci., 1043, 784-792.
22. Cameron, N.E.; Eaton, S.E.; Cotter, M.A. and Tesfaye, S. (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia, 44(11), 1973-1988.
23. Brown, M.J. and Asbury, A.K. (1984) Diabetic neuropathy. Ann. Neurol., 15(1), 2-12.
24. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature, 414(6865), 813-820.
25. Brownlee, M. (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes, 54(6), 1615-1625.
26. Vincent, A.M.; Kato, K.; McLean, L.L.; Soules, M.E. and Feldman, E.L. (2009) Sensory Neurons and Schwann Cells Respond to Oxidative Stress by Increasing Antioxidant Defense Mechanisms. Antioxid. Redox. Signal., 11(3), 425-438.
27. Vincent, A.M.; Russell, J.W.; Low, P. and Feldman, E.L. (2004) Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev., 25(4), 612-628.
28. Vincent, A.M. and Feldman, E.L. (2004) New insights into the mechanisms of diabetic neuropathy. Rev. Endocr. Metab. Disord., 5(3), 227-236.
29. Coppey, L.J.; Gellett, J.S.; Davidson, E.P. and Yorek, M.A. (2003) Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. Free Radic. Res., 37(1), 33-40.
30. Coppey, L.J.; Davidson, E.P.; Dunlap, J.A.; Lund, D.D. and Yorek, M.A. (2000) Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve. Int. J. Exp. Diabetes Res., 1(2), 131-143.
31. Coppey, L.J.; Gellett, J.S.; Davidson, E.P.; Dunlap, J.A.; Lund, D.D. and Yorek, M.A. (2001) Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes, 50(8), 1927-1937.
32. Nickander, K.K.; McPhee, B.R.; Low, P.A. and Tritschler, H. (1996) Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Radic. Biol. Med., 21(5), 631-639.
33. Cameron, N.E. and Cotter, M.A. (1999) Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res. Clin. Pract., 45(2-3), 137-146.
34. Lazarovici, P.; Marcinkiewicz, C. and Lelkes, P.I. (2006) Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr. Pharm. Des., 12(21), 2609-2622.
35. Simovic, D.; Isner, J.M.; Ropper, A.H.; Pieczek, A. and Weinberg, D.H. (2001) Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia. Arch. Neurol., 58(5), 761-768.
36. Schmidt, R.E.; Dorsey, D.A.; Beaudet, L.N.; Plurad, S.B.; Parvin, C.A. and Miller, M.S. (1999) Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy. Am. J. Pathol., 155(5), 1651-1660.
37. Zhuang, H.X.; Snyder, C.K.; Pu, S.F. and Ishii, D.N. (1996) Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats. Exp. Neurol., 140(2), 198-205.
38. Lopez-Lopez, C.; LeRoith, D. and Torres-Aleman, I. (2004) Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc. Natl. Acad. Sci. USA, 101(26), 9833-9838.
39. Salis, M.B.; Graiani, G.; Desortes, E.; Caldwell, R.B.; Madeddu, P. and Emanueli, C. (2004) Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice. Diabetologia, 47(6), 1055-1063.
40. Graiani, G.; Emanueli, C.; Desortes, E.; Van Linthout, S.; Pinna, A.; Figueroa, C.D.; Manni, L. and Madeddu, P. (2004) Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of Type 1 diabetic mice. Diabetologia, 47(6), 1047-1054.
41. Emanueli, C.; Salis, M.B.; Pinna, A.; Graiani, G.; Manni, L. and Madeddu, P. (2002) Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation, 106(17), 2257-2262.
42. Kermani, P.; Rafii, D.; Jin, D.K.; Whitlock, P.; Schaffer, W.; Chiang, A.; Vincent, L.; Friedrich, M.; Shido, K.; Hackett, N.R.; Crystal, R.G.; Rafii, S. and Hempstead, B.L. (2005) Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. J. Clin. Invest., 115(3), 653-663.
43. Kim, H.; Li, Q.; Hempstead, B.L. and Madri, J.A. (2004) Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells. J. Biol. Chem., 279(32), 33538-33546.
44. Unsicker, K.; Reichert-Preibsch, H.; Schmidt, R.; Pettmann, B.; Labourdette, G. and Sensenbrenner, M. (1987) Astroglial and fibroblast growth factors have neurotrophic functions for cultured peripheral and central nervous system neurons. Proc. Natl. Acad. Sci. USA, 84(15), 5459-5463.
45. Lenhard, T.; Schober, A.; Suter-Crazzolara, C. and Unsicker, K. (2002) Fibroblast growth factor-2 requires glial-cell-line-derived neurotrophic factor for exerting its neuroprotective actions on glutamate-lesioned hippocampal neurons. Mol. Cell. Neurosci., 20(2), 181-197.
46. Zacchigna, S.; Lambrechts, D. and Carmeliet, P. (2008) Neurovascular signalling defects in neurodegeneration. Nat. Rev. Neurosci., 9(3), 169-81.
47. Jeong, J.O.; Kim, M.O.; Kim, H.; Lee, M.Y.; Kim, S.W.; Ii, M.; Lee, J.U.; Lee, J.; Choi, Y.J.; Cho, H.J.; Lee, N.; Silver, M.; Wecker, A.; Kim, D.W. and Yoon, Y.S. (2009) Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation, 119(5), 699-708.
48. Kim, H.; Park, J.S.; Choi, Y.J.; Kim, M.O.; Huh, Y.H.; Kim, S.W.; Han, J.W.; Lee, J.; Kim, S.; Houge, M.A.; Ii, M. and Yoon, Y.S. (2009) Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy. Stem Cells, 27(7), 1686-1696.
49. Vincent, K.A.; Shyu, K.G.; Luo, Y.; Magner, M.; Tio, R.A.; Jiang, C.; Goldberg, M.A.; Akita, G.Y.; Gregory, R.J. and Isner, J.M. (2000) Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation, 102(18), 2255-2261.
50. Shweiki, D.; Itin, A.; Soffer, D. and Keshet, E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 359(6398), 843-845.
51. Schratzberger, P.; Schratzberger, G.; Silver, M.; Curry, C.; Kearney, M.; Magner, M.; Alroy, J.; Adelman, L.S.; Weinberg, D.H.; Ropper, A.H. and Isner, J.M. (2000) Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat. Med., 6(4), 405-413.
52. Sondell, M.; Lundborg, G. and Kanje, M. (1999) Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts. Brain Res., 846(2), 219-228.
53. Recio-Pinto, E. and Ishii, D.N. (1984) Effects of insulin, insulinlike growth factor-II and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells. Brain Res., 302(2), 323-334.
54. Recio-Pinto, E.; Lang, F.F. and Ishii, D.N. (1984) Insulin and insulin-like growth factor II permit nerve growth factor binding and the neurite formation response in cultured human neuroblastoma cells. Proc. Natl. Acad. Sci. USA, 81(8), 2562-2566.
55. Fernyhough, P.; Willars, G.B.; Lindsay, R.M. and Tomlinson, D.R. (1993) Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neurones. Brain Res., 607(1-2), 117-124.
56. Near, S.L.; Whalen, L.R.; Miller, J.A. and Ishii, D.N. (1992) Insulin-like growth factor II stimulates motor nerve regeneration. Proc. Natl. Acad. Sci. USA, 89(24), 11716-11720.
57. Bitar, M.S.; Pilcher, C.W.; Khan, I. and Waldbillig, R.J. (1997) Diabetes-induced suppression of IGF-1 and its receptor mRNA levels in rat superior cervical ganglia. Diabetes Res. Clin. Pract., 38(2), 73-80.
58. Cheng, H.L.; Russell, J.W. and Feldman, E.L. (1999) IGF-I promotes peripheral nervous system myelination. Ann. N. Y. Acad. Sci., 883, 124-130.
59. Calcutt, N.A.; Allendoerfer, K.L.; Mizisin, A.P.; Middlemas, A.; Freshwater, J.D.; Burgers, M.; Ranciato, R.; Delcroix, J.D.; Taylor, F.R.; Shapiro, R.; Strauch, K.; Dudek, H.; Engber, T.M.; Galdes, A.; Rubin, L.L. and Tomlinson, D.R. (2003) Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy. J. Clin. Invest., 111(4), 507-514.
60. Sofroniew, M.V.; Howe, C.L. and Mobley, W.C. (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci., 24), 1217-1281.
61. Bandtlow, C.E.; Heumann, R.; Schwab, M.E. and Thoenen, H. (1987) Cellular localization of nerve growth factor synthesis by in situ hybridization. EMBO J., 6(4), 891-899.
62. Crowley, C.; Spencer, S.D.; Nishimura, M.C.; Chen, K.S.; Pitts-Meek, S.; Armanini, M.P.; Ling, L.H.; McMahon, S.B.; Shelton, D.L.; Levinson, A.D. and et al. (1994) Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell, 76(6), 1001-1011.
63. Schratzberger, P.; Walter, D.H.; Rittig, K.; Bahlmann, F.H.; Pola, R.; Curry, C.; Silver, M.; Krainin, J.G.; Weinberg, D.H.; Ropper, A.H. and Isner, J.M. (2001) Reversal of experimental diabetic neuropathy by VEGF gene transfer. J. Clin. Invest., 107(9), 1083-1092.
64. Britland, S.T.; Young, R.J.; Sharma, A.K. and Clarke, B.F. (1990) Relationship of endoneurial capillary abnormalities to type and severity of diabetic polyneuropathy. Diabetes, 39(8), 909-913.
65. Giannini, C. and Dyck, P.J. (1994) Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus. Ann. Neurol., 36(3), 408-415.
66. Malik, R.A.; Newrick, P.G.; Sharma, A.K.; Jennings, A.; Ah-See, A.K.; Mayhew, T.M.; Jakubowski, J.; Boulton, A.J. and Ward, J.D. (1989) Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia, 32(2), 92-102.
67. Malik, R.A.; Tesfaye, S.; Newrick, P.G.; Walker, D.; Rajbhandari, S.M.; Siddique, I.; Sharma, A.K.; Boulton, A.J.; King, R.H.; Thomas, P.K. and Ward, J.D. (2005) Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia, 48(3), 578-585.
68. Malik, R.A.; Tesfaye, S.; Thompson, S.D.; Veves, A.; Sharma, A.K.; Boulton, A.J. and Ward, J.D. (1993) Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia, 36(5), 454-459.
69. Sima, A.A.; Nathaniel, V.; Prashar, A.; Bril, V. and Greene, D.A. (1991) Endoneurial microvessels in human diabetic neuropathy. Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor. Diabetes, 40(9), 1090-1099.
70. Bradley, J.; Thomas, P.K.; King, R.H.; Llewelyn, J.G.; Muddle, J.R. and Watkins, P.J. (1990) Morphometry of endoneurial capillaries in diabetic sensory and autonomic neuropathy. Diabetologia, 33(10), 611-618.
71. Khawaja, K.I.; Walker, D.; Hayat, S.A.; Boulton, A.J. and Malik, R.A. (2000) Clinico-pathological features of postural hypotension in diabetic autonomic neuropathy. Diabet. Med., 17(2), 163-166.
72. Sugimoto, K. and Yagihashi, S. (1997) Effects of aminoguanidine on structural alterations of microvessels in peripheral nerve of streptozotocin diabetic rats. Microvasc. Res., 53(2), 105-112.
73. Yasuda, H.; Sonobe, M.; Yamashita, M.; Terada, M.; Hatanaka, I.; Huitian, Z. and Shigeta, Y. (1989) Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO 2235. Diabetes, 38(7), 832-838.
74. Uehara, K.; Sugimoto, K.; Wada, R.; Yoshikawa, T.; Marukawa, K.; Yasuda, Y.; Kimura, Y. and Yagihashi, S. (1997) Effects of cilostazol on the peripheral nerve function and structure in STZinduced diabetic rats. J. Diabetes Complications, 11(3), 194-202.
75. Estrella, J.S.; Nelson, R.N.; Sturges, B.K.; Vernau, K.M.; Williams, D.C.; LeCouteur, R.A.; Shelton, G.D. and Mizisin, A.P. (2008) Endoneurial microvascular pathology in feline diabetic neuropathy. Microvasc. Res., 75(3), 403-410.
76. Yasuda, H. and Dyck, P.J. (1987) Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology, 37(1), 20-28.
77. Thrainsdottir, S.; Malik, R.A.; Dahlin, L.B.; Wiksell, P.; Eriksson, K.F.; Rosen, I.; Petersson, J.; Greene, D.A. and Sundkvist, G. (2003) Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man. Diabetes, 52(10), 2615-2622.
78. Dyck, P.J.; Hansen, S.; Karnes, J.; O'Brien, P.; Yasuda, H.; Windebank, A. and Zimmerman, B. (1985) Capillary number and percentage closed in human diabetic sural nerve. Proc. Natl. Acad. Sci. USA, 82(8), 2513-2517.
79. Malik, R.A.; Tesfaye, S.; Thompson, S.D.; Veves, A.; Hunter, A.; Sharma, A.K.; Ward, J.D. and Boulton, A.J. (1994) Transperineurial capillary abnormalities in the sural nerve of patients with diabetic neuropathy. Microvasc. Res., 48(2), 236-245.
80. Artico, M.; Massa, R.; Cavallotti, D.; Franchitto, S. and Cavallotti, C. (2002) Morphological changes in the sciatic nerve of diabetic rats treated with low molecular weight heparin OP 2123/parnaparin. Anat. Histol. Embryol., 31(4), 193-197.
81. Hasegawa, T.; Kosaki, A.; Shimizu, K.; Matsubara, H.; Mori, Y.; Masaki, H.; Toyoda, N.; Inoue-Shibata, M.; Nishikawa, M. and Iwasaka, T. (2006) Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats. Exp. Neurol., 199(2), 274-280.
82. Kusano, K.F.; Allendoerfer, K.L.; Munger, W.; Pola, R.; Bosch-Marce, M.; Kirchmair, R.; Yoon, Y.S.; Curry, C.; Silver, M.; Kearney, M.; Asahara, T. and Losordo, D.W. (2004) Sonic hedgehog induces arteriogenesis in diabetic vasa nervorum and restores function in diabetic neuropathy. Arterioscler. Thromb. Vasc. Biol., 24(11), 2102-2107.
83. Zochodne, D.W. and Nguyen, C. (1999) Increased peripheral nerve microvessels in early experimental diabetic neuropathy: quantitative studies of nerve and dorsal root ganglia. J. Neurol. Sci., 166(1), 40-46.
84. Kennedy, J.M. and Zochodne, D.W. (2002) Influence of experimental diabetes on the microcirculation of injured peripheral nerve: functional and morphological aspects. Diabetes, 51(7), 2233-2240.
85. Cameron, N.E.; Cotter, M.A.; Ferguson, K.; Robertson, S. and Radcliffe, M.A. (1991) Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZD rats. Diabetes, 40(12), 1652-1658.
86. Cameron, N.E.; Cotter, M.A. and Robertson, S. (1992) Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocindiabetic rats. Diabetologia, 35(1), 12-18.
87. Jarvis, M.F.; Wessale, J.L.; Zhu, C.Z.; Lynch, J.J.; Dayton, B.D.; Calzadilla, S.V.; Padley, R.J.; Opgenorth, T.J. and Kowaluk, E.A. (2000) ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain. Eur. J. Pharmacol., 388(1), 29-35.
88. Maxfield, E.K.; Love, A.; Cotter, M.A. and Cameron, N.E. (1995) Nerve function and regeneration in diabetic rats: effects of ZD-7155, an AT1 receptor antagonist. Am. J. Physiol., 269(3 Pt 1), E530-E537.
89. Obrosova, I.G.; Van Huysen, C.; Fathallah, L.; Cao, X.; Stevens, M.J. and Greene, D.A. (2000) Evaluation of alpha(1)-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J., 14(11), 1548-1558.
90. Ii, M.; Nishimura, H.; Kusano, K.F.; Qin, G.; Yoon, Y.S.; Wecker, A.; Asahara, T. and Losordo, D.W. (2005) Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy. Circulation, 112(1), 93-102.
91. Emanueli, C.; Schratzberger, P.; Kirchmair, R. and Madeddu, P. (2003) Paracrine control of vascularization and neurogenesis by neurotrophins. Br. J. Pharmacol., 140(4), 614-619.
92. Ernfors, P.; Lee, K.F.; Kucera, J. and Jaenisch, R. (1994) Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell, 77(4), 503-512.
93. Ropper, A.H.; Gorson, K.C.; Gooch, C.L.; Weinberg, D.H.; Pieczek, A.; Ware, J.H.; Kershen, J.; Rogers, A.; Simovic, D.; Schratzberger, P.; Kirchmair, R. and Losordo, D. (2009) Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial. Ann. Neurol., 65(4), 386-393.
94. Mudo, G.; Bonomo, A.; Di Liberto, V.; Frinchi, M.; Fuxe, K. and Belluardo, N. (2009) The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain. J. Neural Transm., 116(8), 995-1005.
95. Nakae, M.; Kamiya, H.; Naruse, K.; Horio, N.; Ito, Y.; Mizubayashi, R.; Hamada, Y.; Nakashima, E.; Akiyama, N.; Kobayashi, Y.; Watarai, A.; Kimura, N.; Horiguchi, M.; Tabata, Y.; Oiso, Y. and Nakamura, J. (2006) Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats. Diabetes, 55(5), 1470-1477.
96. Calcutt, N.A.; Jolivalt, C.G. and Fernyhough, P. (2008) Growth factors as therapeutics for diabetic neuropathy. Curr. Drug Targets, 9(1), 47-59.
97. Apfel, S.C. (1999) Neurotrophic factors in the therapy of diabetic neuropathy. Am. J. Med., 107(2B), 34S-42S.
98. Mizisin, A.P.; Vu, Y.; Shuff, M. and Calcutt, N.A. (2004) Ciliary neurotrophic factor improves nerve conduction and ameliorates regeneration deficits in diabetic rats. Diabetes, 53(7), 1807-1812.
99. Anitha, M.; Gondha, C.; Sutliff, R.; Parsadanian, A.; Mwangi, S.; Sitaraman, S.V. and Srinivasan, S. (2006) GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J. Clin. Invest., 116(2), 344-356.
100. Tacken, P.J.; de Vries, I.J.; Torensma, R. and Figdor, C.G. (2007) Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol., 7(10), 790-802.
101. Prochazka, V.; Gumulec, J.; Chmelova, J.; Klement, P.; Klement, G.L.; Jonszta, T.; Czerny, D. and Krajca, J. (2009) Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot. Vnitr. Lek., 55(3), 173-178.
102. Kamihata, H.; Matsubara, H.; Nishiue, T.; Fujiyama, S.; Tsutsumi, Y.; Ozono, R.; Masaki, H.; Mori, Y.; Iba, O.; Tateishi, E.; Kosaki, A.; Shintani, S.; Murohara, T.; Imaizumi, T. and Iwasaka, T. (2001) Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation, 104(9), 1046-1052.
103. Shintani, S.; Murohara, T.; Ikeda, H.; Ueno, T.; Honma, T.; Katoh, A.; Sasaki, K.; Shimada, T.; Oike, Y. and Imaizumi, T. (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation, 103(23), 2776-2779.
104. Tateishi-Yuyama, E.; Matsubara, H.; Murohara, T.; Ikeda, U.; Shintani, S.; Masaki, H.; Amano, K.; Kishimoto, Y.; Yoshimoto, K.; Akashi, H.; Shimada, K.; Iwasaka, T. and Imaizumi, T. (2002) Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet, 360(9331), 427-435.
105. Risau, W. (1997) Mechanisms of angiogenesis. Nature, 386(6626), 671-674.
106. Carmeliet, P. and Jain, R.K. (2000) Angiogenesis in cancer and other diseases. Nature, 407(6801), 249-257.
107. Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; van der Zee, R.; Li, T.; Witzenbichler, B.; Schatteman, G. and Isner, J.M. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275(5302), 964-967.
108. Asahara, T.; Takahashi, T.; Masuda, H.; Kalka, C.; Chen, D.; Iwaguro, H.; Inai, Y.; Silver, M. and Isner, J.M. (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J., 18(14), 3964-3972.
109. Kocher, A.A.; Schuster, M.D.; Szabolcs, M.J.; Takuma, S.; Burkhoff, D.; Wang, J.; Homma, S.; Edwards, N.M. and Itescu, S. (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med., 7(4), 430-436.
110. Shi, Q.; Rafii, S.; Wu, M.H.; Wijelath, E.S.; Yu, C.; Ishida, A.; Fujita, Y.; Kothari, S.; Mohle, R.; Sauvage, L.R.; Moore, M.A.; Storb, R.F. and Hammond, W.P. (1998) Evidence for circulating bone marrow-derived endothelial cells. Blood, 92(2), 362-367.
111. Gehling, U.M.; Ergun, S.; Schumacher, U.; Wagener, C.; Pantel, K.; Otte, M.; Schuch, G.; Schafhausen, P.; Mende, T.; Kilic, N.; Kluge, K.; Schafer, B.; Hossfeld, D.K. and Fiedler, W. (2000) In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood, 95(10), 3106-3112.
112. Peichev, M.; Naiyer, A.J.; Pereira, D.; Zhu, Z.; Lane, W.J.; Williams, M.; Oz, M.C.; Hicklin, D.J.; Witte, L.; Moore, M.A. and Rafii, S. (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 95(3), 952-958.
113. Lin, Y.; Weisdorf, D.J.; Solovey, A. and Hebbel, R.P. (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest., 105(1), 71-77.
114. Hur, J.; Yoon, C.H.; Kim, H.S.; Choi, J.H.; Kang, H.J.; Hwang, K.K.; Oh, B.H.; Lee, M.M. and Park, Y.B. (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol., 24(2), 288-293.
115. Rehman, J.; Li, J.; Orschell, C.M. and March, K.L. (2003) Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation, 107(8), 1164-1169.
116. Kalka, C.; Masuda, H.; Takahashi, T.; Kalka-Moll, W.M.; Silver, M.; Kearney, M.; Li, T.; Isner, J.M. and Asahara, T. (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA, 97(7), 3422-3427.
117. Yoon, C.H.; Hur, J.; Park, K.W.; Kim, J.H.; Lee, C.S.; Oh, I.Y.; Kim, T.Y.; Cho, H.J.; Kang, H.J.; Chae, I.H.; Yang, H.K.; Oh, B.H.; Park, Y.B. and Kim, H.S. (2005) Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation, 112(11), 1618-1627.
118. Peters, B.A.; Diaz, L.A.; Polyak, K.; Meszler, L.; Romans, K.; Guinan, E.C.; Antin, J.H.; Myerson, D.; Hamilton, S.R.; Vogelstein, B.; Kinzler, K.W. and Lengauer, C. (2005) Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat. Med., 11(3), 261-262.
119. Yeh, E.T.; Zhang, S.; Wu, H.D.; Korbling, M.; Willerson, J.T. and Estrov, Z. (2003) Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation, 108(17), 2070-2073.
120. O'Neill, T.J.T.; Wamhoff, B.R.; Owens, G.K. and Skalak, T.C. (2005) Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ. Res., 97(10), 1027-1035.
121. Ziegelhoeffer, T.; Fernandez, B.; Kostin, S.; Heil, M.; Voswinckel, R.; Helisch, A. and Schaper, W. (2004) Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res., 94(2), 230-238.
122. Naruse, K.; Hamada, Y.; Nakashima, E.; Kato, K.; Mizubayashi, R.; Kamiya, H.; Yuzawa, Y.; Matsuo, S.; Murohara, T.; Matsubara, T.; Oiso, Y. and Nakamura, J. (2005) Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes, 54(6), 1823-1828.
123. Cho, H.J.; Lee, N.; Lee, J.Y.; Choi, Y.J.; Ii, M.; Wecker, A.; Jeong, J.O.; Curry, C.; Qin, G. and Yoon, Y.S. (2007) Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J. Exp. Med., 204(13), 3257-3269.
124. Abe, K. and Saito, H. (2000) Neurotrophic effect of basic fibroblast growth factor is mediated by the p42/p44 mitogen-activated protein kinase cascade in cultured rat cortical neurons. Brain Res. Dev. Brain Res., 122(1), 81-85.
125. Chalasani, S.H.; Baribaud, F.; Coughlan, C.M.; Sunshine, M.J.; Lee, V.M.; Doms, R.W.; Littman, D.R. and Raper, J.A. (2003) The chemokine stromal cell-derived factor-1 promotes the survival of embryonic retinal ganglion cells. J. Neurosci., 23(11), 4601-4612.
126. Mirshahi, F.; Pourtau, J.; Li, H.; Muraine, M.; Trochon, V.; Legrand, E.; Vannier, J.; Soria, J.; Vasse, M. and Soria, C. (2000) SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models. Thromb. Res., 99(6), 587-594.
127. Masaki, I.; Yonemitsu, Y.; Yamashita, A.; Sata, S.; Tanii, M.; Komori, K.; Nakagawa, K.; Hou, X.; Nagai, Y.; Hasegawa, M.; Sugimachi, K. and Sueishi, K. (2002) Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ. Res., 90(9), 966-973.
128. Balsam, L.B.; Wagers, A.J.; Christensen, J.L.; Kofidis, T.; Weissman, I.L. and Robbins, R.C. (2004) Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature, 428(6983), 668-673.
129. Muller-Ehmsen, J.; Krausgrill, B.; Burst, V.; Schenk, K.; Neisen, U.C.; Fries, J.W.; Fleischmann, B.K.; Hescheler, J. and Schwinger, R.H. (2006) Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J. Mol. Cell. Cardiol., 41(5), 876-884.
130. Orlic, D.; Kajstura, J.; Chimenti, S.; Limana, F.; Jakoniuk, I.; Quaini, F.; Nadal-Ginard, B.; Bodine, D.M.; Leri, A. and Anversa, P. (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA, 98(18), 10344-10349.
131. Gao, D.; Nolan, D.J.; Mellick, A.S.; Bambino, K.; McDonnell, K. and Mittal, V. (2008) Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science, 319(5860), 195-198.
132. Kim, H.; Kim, S.W.; Nam, D.; Kim, S. and Yoon, Y.S. (2009) Cell therapy with bone marrow cells for myocardial regeneration. Antioxid. Redox. Signal., 11(8), 1897-1911.
133. Flores-Ramirez, R.; Uribe-Longoria, A.; Rangel-Fuentes, M.M.; Gutierrez-Fajardo, P.; Salazar-Riojas, R.; Cervantes-Garcia, D.; Trevino-Ortiz, J.H.; Benavides-Chereti, G.J.; Espinosa-Oliveros, L.P.; Limon-Rodriguez, R.H.; Monreal-Puente, R.; Gonzalez-Trevino, J.L. and Rojas-Martinez, A. (2010) Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency. Cardiovasc. Revasc. Med., 11(2), 72-78.
134. Ii, M.; Nishimura, H.; Iwakura, A.; Wecker, A.; Eaton, E.; Asahara, T. and Losordo, D.W. (2005) Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation, 111(9), 1114-1120.
135. Abdel-Latif, A.; Bolli, R.; Tleyjeh, I.M.; Montori, V.M.; Perin, E.C.; Hornung, C.A.; Zuba-Surma, E.K.; Al-Mallah, M. and Dawn, B. (2007) Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Intern. Med., 167(10), 989-997.
136. Habib, A.A. and Brannagan, T.H. 3rd. (2010) Therapeutic strategies for diabetic neuropathy. Curr. Neurol. Neurosci. Rep., 10(2), 92-100.
137. Schonauer, M.; Thomas, A.; Morbach, S.; Niebauer, J.; Schonauer, U. and Thiele, H. (2008) Cardiac autonomic diabetic neuropathy. Diab. Vasc. Dis. Res., 5(4), 336-344.
138. Maser, R.E.; Mitchell, B.D.; Vinik, A.I. and Freeman, R. (2003) The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care, 26(6), 1895-1901.
139. Yamanaka, S. (2009) A fresh look at iPS cells. Cell, 137(1), 13-17.